Cognitive behavioral therapy for reducing fatigue in chronic kidney disease
A Pilot Trial of Strategies to Reduce Fatigue for People With Chronic Kidney Disease (CKD)
This study is testing a new therapy to see if it can help people with chronic kidney disease feel less tired.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06768983 on ClinicalTrials.gov |
What this trial studies
This pilot trial aims to test the acceptability and proof of concept of a cognitive behavioral intervention designed to reduce fatigue in patients with chronic kidney disease. The study employs a one-group design, integrating both qualitative and quantitative data collection methods to assess the intervention's effectiveness. Participants will engage in remote study sessions and provide feedback on their experiences. The findings from this pilot will inform a larger trial seeking federal funding.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with chronic kidney disease and an eGFR of 15-44 mL/min/1.73 m2 who are interested in participating in a fatigue study.
Not a fit: Patients currently involved in an exercise program or those with a high likelihood of needing a kidney transplant within the next six months may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly alleviate fatigue in patients with chronic kidney disease, improving their quality of life.
How similar studies have performed: While this approach is relatively novel, previous studies have shown cognitive behavioral therapy to be effective in managing fatigue in other chronic conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Interest in participating in a fatigue study * Age ≥18 years old * Estimated glomerular filtration rate (eGFR) 15-44 mL/min/1.73 m2 * Ability and willingness to provide informed consent * Ability to speak English * Ability to walk * Ability to join remote study sessions via WebEx Exclusion Criteria: * Current involvement in an activity/exercise program * High likelihood of a kidney transplant within 6 months (assessed via the medical record) * Any safety concerns about increased walking (assessed via the medical record)
Where this trial is running
New York, New York
- NYU Langone Health — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Daniel Cukor, PhD — NYU Langone Health
- Study coordinator: Daniel Cukor, PhD
- Email: Daniel.Cukor@nyulangone.org
- Phone: (212) 263-5635
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.